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Abstract The pituitary is an essential endocrine gland regulating multiple processes.
Regeneration of endocrine cells is of therapeutic interest and recent studies are promising, but
mechanisms of endocrine cell fate acquisition need to be better characterised. The NOTCH
pathway is important during pituitary development. Here, we further characterise its role in the
murine pituitary, revealing differential sensitivity within and between lineages. In progenitors,
NOTCH activation blocks cell fate acquisition, with time-dependant modulation. In differentiating
cells, response to activation is blunted in the POU1F1 lineage, with apparently normal cell fate
specification, while POMC cells remain sensitive. Absence of apparent defects in Pou1f1-Cre;
Rbpjfl/fl mice further suggests no direct role for NOTCH signalling in POU1F1 cell fate acquisition.
In contrast, in the POMC lineage, NICD expression induces a regression towards a progenitor-like
state, suggesting that the NOTCH pathway specifically blocks POMC cell differentiation. These
results have implications for pituitary development, plasticity and regeneration. Activation of
NOTCH signalling in different cell lineages of the embryonic murine pituitary uncovers an
unexpected differential sensitivity, and this consequently reveals new aspects of endocrine lineages
development and plasticity.
DOI: https://doi.org/10.7554/eLife.33318.001
Introduction
The pituitary is an essential endocrine gland that is closely associated with the hypothalamus, in the
ventral diencephalon, which controls its hormonal secretions. Pituitary hormones regulate different
aspects of metabolism hence they are involved in maintenance of organism homeostasis, and impor-
tant physiological functions such as growth, reproduction and stress. In consequence, pituitary hor-
mone deficiencies, either congenital (1 in 3500 to 10000 births) (Alatzoglou and Dattani, 2009) or
acquired later in life, mostly caused by tumours or brain damage, are associated with significant mor-
bidity. We, and others, have characterized a population of stem cells (SCs) in the mouse pituitary
(Rizzoti et al., 2013) (Andoniadou et al., 2013). In addition, the differentiation of embryonic SC to
generate endocrine cells has been demonstrated in vitro (Suga et al., 2011). It would be of thera-
peutic interest to utilize SCs to generate endocrine cells; however, the limited efficiency of current
protocols highlights the requirement for improved characterization of the mechanisms of endocrine
cell fate acquisition.
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The pituitary rudiment, or Rathke’s Pouch (RP), develops from the oral ectoderm. It comprises
progenitors that will give rise to the pituitary anterior lobe (AL) ventrally, and the intermediate lobe
(IL) dorsally. The AL comprises five pituitary endocrine cell types (somatotrophs, lactotrophs, thyro-
trophs, corticotrophs and gonadotrophs), while the IL contains exclusively melanotrophs (for review
see (Rizzoti, 2015)). The third lobe, or posterior lobe (PL), is of neural origin and is comprised of
glial cells and vasopressin and oxytocin hypothalamic axon terminals. During early pituitary develop-
ment, RP progenitors initially proliferate, then gradually commit towards endocrine cell fates. Cell
fate acquisition is associated with exit from mitosis (Bilodeau et al., 2009) and an Epithelial to Mes-
enchymal Transition (EMT)-like process (Pe´rez Milla´n et al., 2016). Birth-dating studies have more-
over shown that the different endocrine lineages emerge during the same period, mostly between
11.5 and 13.5dpc in the mouse (Davis et al., 2011). The molecular events underlying endocrine dif-
ferentiation have been relatively well described for each endocrine cell type. Within each lineage,
expression of specific transcription factors is initiated as progenitors commit to an endocrine fate,
such as TBX19 (also known as TPIT) along with NEUROD1 in future corticotrophs or with PAX7 in
prospective melanotrophs, POU1F1 (also known as PIT1) in future somatotrophs, lactotrophs and
thyrotrophs, and SF1 for gonadotroph cell fate (for review see (Rizzoti, 2015)). It is still unclear how-
ever how the endocrine cell fates are initially specified, but the NOTCH pathway is known to be
involved.
The NOTCH pathway plays a central role during cell fate acquisition in different organs. In verte-
brates, the ligands, Delta-like or Jagged proteins, activate the transmembrane receptors NOTCH1-
4. Following activation, cleavage of the NOTCH Intracellular Domain (NICD) allows its translocation
to the nucleus, resulting in activation of target genes, such as the HES bHLH transcription factors, by
the pathway nuclear effector RBPJ. Deregulation of the pathway is associated with inherited and
degenerative diseases, but also with cancers in humans (for review see (Hori et al., 2013)). In the
pituitary, the receptors NOTCH 2 and 3, the ligands Jagged one and Delta-like 1, and downstream
effectors of the HES and HEY families are expressed in embryonic progenitors; as endocrine lineages
emerge expression of these genes is mostly confined to SCs and this persists post-natally
(Chen et al., 2006; Raetzman et al., 2004; Zhu et al., 2006). In contrast, the ligands Dll1 and 3,
and HES6, that does not bind DNA itself but suppresses HES1 activity, are present in differentiating
cells, suggesting that the pathway is also active once cell fate is acquired (Raetzman et al., 2004).
Studies investigating the consequences of conditional deletion of RBPJ (Zhu et al., 2015; Zhu et al.,
2006), Notch2 and loss of the NOTCH targets Hes1 and Hes5 (Kita et al., 2007; Raetzman et al.,
2007) (Nantie et al., 2014) support a role for NOTCH pathway in maintenance of an undifferenti-
ated proliferative state to allow emergence of the different endocrine cell types. In contrast, overac-
tivation of the pathway by conditional expression of NICD in either committed progenitors
(Zhu et al., 2006), or differentiated corticotrophs and melanotrophs constituting the POMC lineage
(Goldberg et al., 2011), results in a blockade of cell differentiation.
To better characterize the role of the NOTCH pathway during pituitary development, we have
here manipulated its activity and compared outcomes in different cellular contexts. Using Sox2-
CreERT2 (Arnold et al., 2011) and Nkx3.1Cre (Lin et al., 2007), we show that progenitors are particu-
larly sensitive to NOTCH signalling, as cell fate acquisition is mostly prevented by NOTCH over-
activation. However, we reveal that timing and/or duration of activation modulates cell responses;
early activation results in exclusion of cells from the future IL, while activated cells remain in the IL if
induction is performed 72 hr later. In contrast, in POU1F1 positive committed cells, NICD expression
results in a blunted activation of NOTCH target genes. In consequence, there is no apparent effect
on differentiation of somatotrophs, thyrotrophs and lactotrophs. However post-natally, as activation
becomes more efficient, there is a reduction in Growth Hormone (GH) pituitary contents, suggesting
that the function of GH-secreting somatotrophs is altered. Nonetheless, and in agreement with a
minor role of NOTCH pathway in this lineage, we observe that deletion of Rbpj using the same
POU1F1-Cre does not affect GH levels. Intrigued by the relatively modest effect of NOTCH activa-
tion in the POU1F1 lineage, we expressed NICD in the POMC lineage, where we observe an efficient
activation of the pathway, showing that corticotrophs and melanotrophs remain sensitive to NOTCH
activation. While cell fate acquisition did not appear affected initially, we observe a fast downregula-
tion of differentiation markers expression, while SC markers are up-regulated, as well as a spectacu-
lar regression of IL soon after birth. This study uncovers an unexpected differential sensitivity to
NOTCH activity according to timing and lineage identity. We propose that the sensitivity of the
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POMC lineage to NICD activity reflects a specific physiological requirement of NOTCH pathway to
prevent differentiation toward the first endocrine cell lineage to emerge, the corticotrophs. More-
over, the lasting sensitivity of this lineage may have a pathological relevance because NOTCH activa-
tion has been associated with tumorigenesis.
Results
Activation of NOTCH pathway in RP progenitors efficiently blocks cell
fate acquisition
We initially examined cell fate acquisition potential after over-activation of the NOTCH pathway in
RP progenitors. For this purpose, we used Sox2CreERT2 (Arnold et al., 2011) and Nkx3.1Cre
(Lin et al., 2007) to induce recombination of Rosa26floxSTOP-NICD1 (Murtaugh et al., 2003) and
Rosa26floxSTOP-NICD2 (Fujimura et al., 2010) alleles. We used Rosa26floxSTOP-NICD1 because other
studies where NOTCH pathway was activated utilised this allele (Goldberg et al., 2011; Zhu et al.,
2006). However, NOTCH1 is not expressed in the pituitary while NOTCH2 is, so we also used
Rosa26floxSTOP-NICD2 (Raetzman et al., 2004). SOX2 is present in all pituitary progenitors
(Fauquier et al., 2008; Rizzoti et al., 2013), while NKX3.1 is expressed predominantly in those
located in the dorsal pituitary, peaking at 12.5dpc (Treier et al., 1998) (Goldsmith et al., 2016).
Lineage tracing analysis of NKX3.1Cre confirms that this driver is predominantly active in future mel-
anotrophs, and also, albeit less efficiently, in all anterior lobe endocrine populations (Figure 1A–B).
We first verified that the NOTCH pathway was activated following induction of NICD expression
in Nkx3.1Cre/+;Rosa26floxSTOP-NICD1/+ and Nkx3.1Cre/+;Rosa26floxSTOP-NICD2/+ pituitaries. We quanti-
fied expression levels for several NOTCH target gene transcripts at 18.5dpc (Figure 1C). We used
quantitative PCR (RT-qPCR) and observed a significant induction of targets of the Hes and Hey fami-
lies, showing that NOTCH pathway can be efficiently over-activated in RP progenitors. We observe a
particularly potent induction of Hes5. Hes1 and Hes5 are closely related and are frequently
expressed in complementary patterns, in particular in the developing nervous system
(Hatakeyama et al., 2004). In the developing pituitary, Hes5 expression has previously been
described as undetectable, but it is up-regulated upon deletion of Hes1 and compensates for its
loss (Kita et al., 2007). Therefore induction of Hes5 expression in Nkx3.1Cre/+;Rosa26floxSTOP- NICD1
or 2/+ is physiologically relevant.
We then analysed expression levels of markers for endocrine and progenitor cells in Nkx3.1Cre/+;
Rosa26floxSTOP- NICD1 or 2/+ pituitaries at E18.5 by RT-qPCR (Figure 1C–D). The transcription factor
PROP1 is expressed in pituitary progenitors where it is required for cell fate progression toward
commitment (Pe´rez Milla´n et al., 2016) and has been proposed to be a direct target of NOTCH
pathway (Zhu et al., 2006). In agreement with these data, we observe an upregulation of its expres-
sion upon NOTCH activation, which only reaches significance using the NICD2 allele (Figure 1C).
Prop1 is rapidly down-regulated as cells differentiate (Yoshida et al., 2009; Yoshida et al., 2011),
therefore, up-regulation of its expression suggests an impairment in cell differentiation. Persistent
NICD1, but not NICD2, expression leads indeed to a significant reduction in Pou1f1, which encodes
a transcription factor required for maintenance of GH (growth hormone), PRL (prolactin secreted by
lactotrophs) and TSH (thyroid-stimulating hormone secreted by thyrotrophs) secreting cells
(Bodner et al., 1988) (Figure 1D). In addition, we also observe a reduction in the expression of
Pax7, the product of which is a pioneer factor for melanotroph fate (Budry et al., 2012), and Pomc
(proopiomelanocortin), which encodes the precursor of the hormone secreted by corticotrophs
(ACTH, adrenocorticotropic hormone) and melanotrophs (MSH, melanocyte stimulating hormone)
when either NICD1 or NICD2 are overexpressed (Figure 1D). In contrast, expression of Sox2 is not
significantly altered. In summary, these results indicate that melanotrophs, endocrine cells of the
POU1F1 lineage, and possibly corticotrophs, are affected by NOTCH over-activation. In addition,
NICD1 appears more efficient, and/or has a specific effect on the POU1F1 lineage that we do not
observe using NICD2 (Figure 1D), suggesting non-redundant function for NOTCH cellular domains.
We subsequently performed 3D reconstitution of Nkx3.1Cre/+;Rosa26floxSTOP NICD1 or 2/+ pituitaries
at 15.5dpc (Figure 1E). We observe clear malformations of the gland with varying degrees of sever-
ity. Using NICD1, 2 out of 7 mutant embryos presented a severe phenotype, while using NICD2, 3
out of 5 were severely affected, suggesting that NICD2 was associated with more serious defects.
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Figure 1. Activation of NOTCH pathway in progenitors efficiently blocks cell fate acquisition. (A) Immunofluorescence of 18.5dpc Nkx3.1Cre/+;
Rosa26ReYFP/+ pituitaries. This lineage tracing analysis shows that NKX3.1Cre is active in precursors for different endocrine cells. (B) Percentage of eYFP
positive endocrine cells for each hormone-secreting population in 18.5dpc Nkx3.1Cre/+; Rosa26ReYFP/+ 18.5 dpc pituitaries. Nkx3.1Cre is mostly active in
IL precursors with POMC;eYFP double positive representing 92% (±1.8 SD, n = 3) of POMC positive melanotrophs, and 55.4% (±3.6 SD, n = 3) of POMC
positive corticotrophs. The other AL cell types are also present in the progeny of NKX3.1 expressing progenitors with GH;eYFP double positive
Figure 1 continued on next page
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However, this effect may be confounded by varying levels of Cre activity because other studies utiliz-
ing Nkx3.1Cre have also reported variations in phenotype severity such as prostate defects in
Nkx3.1Cre;Fgfr2flox/flox mutants (Lin et al., 2007), and spinal defects in Nkx3.1Cre;Erk5flox/flox animals
(Loveridge et al., 2017). The AL appears smaller, particularly the lateral wings of the developing
gland. In addition, the progenitor zone, surrounding the pituitary cleft appears enlarged and folded,
suggesting a retention of progenitors. The sphenoid bone is sometimes affected (Figure 1E, high
severity phenotype) and this could be a direct consequence of the activity of NKX3.1Cre in the
developing skeleton, or indirectly because of the abnormal development of the gland, as we
observed previously in Sox2fl/fl;Nkx3.1Cre/+ embryos (Goldsmith et al., 2016). Over-activation of
NOTCH signalling in the developing skeleton causes severe developmental abnormalities
(Hosaka et al., 2013) and this likely explains the lethality of Nkx3.1Cre/+;Rosa26floxSTOPNICD1 or 2/+
newborns.
We next assessed cell fate acquisition potential in mutant pituitaries by analysing the number of
NICD1 expressing cells maintaining expression of SOX2 at 18.5dpc (Figure 1F–H). We restricted
here our analysis to NICD1 as this allele seemed to affect endocrine lineages more efficiently than
NICD2 (Figure 1D). We can identify cells in which Rosa26floxSTOPNICD1 has been recombined because
they express GFP, as the NICD allele includes an IRES-nuclearGFP cassette (Murtaugh et al., 2003)
(Figure 1F). We analysed embryos expressing Sox2CreERT2, induced at 9.5dpc, or Nkx3.1Cre in com-
bination with Rosa26floxSTOPNICD1 and, as controls, with the Cre reporter allele
Rosa26ReYFP(Srinivas et al., 2001)). Of note, cellular patterns of NICD1iresGFP and eYFP expression
differ because GFP is nuclear while eYFP is present throughout the cell, resulting in apparently
increased levels of eYFP. However, we observed that the number of fluorescent cells resulting from
recombination of the Rosa26ReYFP allele always appears higher than that of GFP from Rosa26floxSTOP-
NICD1, particularly when we use an inducible Cre (Figure 1F). This is therefore likely due to a differ-
ence in recombination efficiency between the two alleles. In addition, GFP in Rosa26floxSTOPNICD1 is
Figure 1 continued
representing 51.9% (±2 SD, n = 2) of somatotrophs, PRL;eYFP double positive representing 34.6% (±2.4 SD, n = 3) of lactotrophs, TSH;eYFP double
positive representing 31.7% (±4.2 SD, n = 3) of thyrotrophs and LH;eYFP double positive representing 38.2% (±7.1 SD, n = 3) of gonadotrophs. (C) RT-
qPCR analysis of NOTCH target genes in Nkx3.1Cre/+;Rosa26flSTOPNICD1/+ and Nkx3.1Cre/+;Rosa26flSTOPNICD2/+ pituitaries at 18.5dpc (n = 3 to 4 embryos/
genotype, Nkx3.1Cre/+;Rosa26flSTOPNIC/+D –T for NICD transgenic - versus Rosa26flSTOPNICD/+ -NT for non-NICD transgenic- littermates, unpaired t test
performed). There is a significant induction of NOTCH pathway target gene expression, particularly of Hes5. (D) RT-qPCR analysis of pituitary cell-type
markers in Nkx3.1Cre/+;Rosa26flSTOPNICD1/+ and Nkx3.1Cre/+;Rosa26flSTOPNICD2/+ pituitaries at 18.5dpc (n = 3 to 6 embryos/genotype, unpaired t test
performed). POMC lineage markers (Pax7 and POMC) are affected by NICD1 and 2 over-expression, while Pit1 and Gh are only affected by NICD1
induction. (E) 3D reconstruction of 15.5dpc Nkx3.1Cre/+;Rosa26flSTOPNICD/+ pituitaries. Soft tissues are false-coloured in green and the basisphenoid
bone in red. Severity of the phenotype is variable with most affected embryos showing misfolding of the epithelium lining the Rathke’s pouch lumen,
reduction of the lateral pituitary wings and no midline fusion of the basisphenoid bone. (F) Immunofluorescence of 18.5dpc Sox2CreERT2/+;
Rosa26ReYFP/+and Sox2CreERT2/+;Rosa26flSTOPNICD1/+pituitaries induced at 9.5dpc. There is a mosaic pattern of eYFP/GFP expression with eYFP
expression being more robust than GFP. In contrast with eYFP in control embryos, most NICD1iresGFP positive cells appear SOX2 positive. In addition,
GFP positive cells do not express GH or POMC. Finally, there are no GFP positive cells in IL. (G) Immunofluorescence of 18.5dpc Nkx3.1Cre/+;
Rosa26ReYFP and Nkx3.1Cre/+;Rosa26flSTOPNICD1/+. IL in Nkx3.1Cre/+;Rosa26flSTOPNICD1/+ is misfolded and hypomorphic. GFP positive cells, both in IL and
AL appear to retain high levels of SOX2. Scale bars represent 100 mm for A and 50 mm for F and G. IL is underlined. H.Quantification of the proportion
of recombined cells maintaining expression of SOX2 in AL at 18.5dpc. There is a significant increase in the proportion of recombined cells retaining
SOX2 expression when NICD is present (n = 3 pituitary/genotype). Moreover this effect is significantly more robust in Sox2CreERT2/+;Rosa26flSTOPNICD1/+
compared to Nkx3.1Cre/+;Rosa26flSTOPNICD1/+. Data are presented as mean ± SD, unpaired t test performed, p=0.0003 when comparing Sox2CreERT2/+;
Rosa26ReYFP/+and Sox2CreERT2/+;Rosa26flSTOPNICD1/+, p=0.0001 when comparing Nkx3.1Cre/+;Rosa26ReYFP and Nkx3.1Cre/+;Rosa26flSTOPNICD1/+ and 0.0299
when comparing Sox2CreERT2/+;Rosa26flSTOPNICD1/+ and Nkx3.1Cre/+;Rosa26flSTOPNICD1/. P is calculated after angular transformation of percentages, n = 3
for each genotype.
DOI: https://doi.org/10.7554/eLife.33318.002
The following source data and figure supplements are available for figure 1:
Source data 1. Countings for graph H.
DOI: https://doi.org/10.7554/eLife.33318.005
Figure supplement 1. IL recombined cells in 12.5dpc Sox2CreERT2/+;Rosa26flSTOPNICD1/+ Rathke’s pouch are not eliminated by apoptosis.
DOI: https://doi.org/10.7554/eLife.33318.003
Figure supplement 2. SOX9 is up-regulated in Sox2CreERT2/+;Rosa26flSTOPNICD1/+ progenitors.
DOI: https://doi.org/10.7554/eLife.33318.004
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preceded by an IRES and this could result in reduced expression levels. We did not observe any
TUNEL activity so this difference is not due to a loss of GFP positive cells by apoptosis (Figure 1—
figure supplement 1). In control Cre; Rosa26ReYFP/+ embryos quantification revealed only a small
proportion, less than 10%, of recombined cells retaining expression of SOX2 in AL (we excluded the
cleft region where SOX2 positive progenitors are maintained), because the vast majority of early pro-
genitors have differentiated at this stage (Rizzoti et al., 2013). In contrast, in either Nkx3.1Cre/+ or
Sox2CreERT2/+;Rosa26floxSTOPNICD1/+ embryos, the majority of recombined cells maintain SOX2
expression and do not express endocrine differentiation markers such as GH and POMC (Figure 1.
F-H and Figure 2A). Expression of SOX9, another marker of pituitary SC (Fauquier et al., 2008;
Rizzoti et al., 2013), is observed in most NICD1iresnucGFP positive cells (Figure 1—figure supple-
ment 2). Therefore, over-activation of the NOTCH pathway in RP progenitors efficiently blocks cell
fate acquisition. In addition, timing and/or duration of NOTCH activation appear important, because
the earliest it is induced, comparing Sox2CreERT2 induced at 9.5dpc (84% SOX2;GFP double positive/
GFP at 18.5dpc) and Nkx3.1Cre, active at 12.5dpc (60% SOX2;GFP double positive/GFP at 18.5dpc),
the more potent is its effect (Figure 1H).
Temporal modulation of over-activation of NOTCH in progenitors has
contrasting phenotypic consequences on IL development
When comparing Sox2CreERT2 and Nkx3.1Cre;Rosa26floxSTOPNICD1 pituitaries at 18.5dpc we noticed
an obvious difference in the IL (Figure 1F,G, lower panels). NKX3.1Cre is mostly active in dorsal RP
and cell recombination is essentially ubiquitous in the prospective IL. As a consequence, and in
agreement with a blockade of cell differentiation induced by NOTCH over-activation, melanotrophs
are dramatically reduced in Nkx3.1Cre;Rosa26floxSTOP-NICD1 (Figure 2A) while instead SOX2 is main-
tained at high levels (Figure 1G). However, some cells are still able to commit to a melanotroph
fate, because a proportion of NICD1iresnucGFP positive cells express low levels of PAX7, but are
unable to upregulate POMC (Figure 2B). In sharp contrast, we do not observe any NICD1ires-
nucGFP-positive cells in Sox2CreERT2;Rosa26floxSTOPNICD1 IL, when Cre is induced at 9.5dpc
(Figure 1F lower panel). This is clearly due to NOTCH activation, because in Sox2CreERT2/+;Rosa26R-
eYFP/+ pituitaries, IL comprises eYFP-positive cells, which as expected reveal a mosaic pattern of
induction of cell recombination following tamoxifen induction (Figure 1F upper panel).
The differential distribution of NICD1iresnucGFP-positive cells in Sox2CreERT2 and Nkx3.1Cre;
Rosa26floxSTOPNICD1 IL could be due to a difference in the pattern of recombination. This is because
Nkx3.1Cre is active homogenously across what will become the IL while Sox2CreERT2 is induced in a
mosaic pattern. Alternatively, or in addition, the difference could be explained by the variation in
timing of activation because Nkx3.1Cre is mostly active at 12.5dpc, 72 hr after we induced Sox2-
CreERT2 at 9.5dpc. To discriminate between these two explanations, we examined Sox2CreERT2;
Rosa26floxSTOPNICD1 IL following induction at 12.5dpc, mimicking Nkx3.1Cre timing, but in a mosaic
pattern. At 18.5dpc we observe NICD1iresnucGFP positive cells in IL (Figure 2C). In addition, simi-
larly to what we saw in Nkx3.1Cre;Rosa26floxSTOP-NICD1 IL, these cells are unable to upregulate POMC
expression, but some commit to a melanotroph fate and express low levels of PAX7 (Figure 2D).
Therefore, it is the variation in timing of activation in dorsal RP that underlines the phenotypic differ-
ences observed between Sox2CreERT2;Rosa26floxSTOPNICD1 induced at 9.5dpc and Nkx3.1Cre;
Rosa26floxSTOPNICD1.
To understand how recombined cells disappear from the IL of Sox2CreERT2/+;Rosa26floxSTOPNICD1
induced at 9.5dpc, we harvested pituitaries earlier during embryogenesis (Figure 2E). We never
detected TUNEL-positive cells in IL (Figure 1—figure supplement 1). However, at 12.5dpc we
observed IL NICD1iresnucGFP-positive cells and these are essentially restricted to the ventral most
part of the developing IL, while control embryos show an equal distribution across IL (Figure 2G).
More precisely, we observe patches of IL NICD1iresnucGFP positive cells apparently reaching
toward the AL progenitor layer (Figure 2E). We do also observe regions of apparent contact
between the future IL and AL in control embryos, but these are rare (Figure 2—figure supplement
1). To assess epithelial integrity in mutant cells, we examined E-cadherin and ZO-1 expression, pres-
ent respectively in adherent and tight junctions. Alterations in localisation of both proteins, normally
present in the apical lateral membranes, are observed with a relocalisation around the plasma mem-
brane, and sometimes loss from the apical ones, in IL NICD1iresnucGFP-positive cells closest to
Rathke’s cleft. This suggests a loss of epithelial polarity of mutant cells (Figure 2E,F). Experimental
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Figure 2. Differential timing of NOTCH activation IL progenitors has contrasting phenotypic consequences. (A) Immunofluorescence of 18.5dpc
Nkx3.1Cre/+;Rosa26ReYFP and Nkx3.1Cre/+;Rosa26flSTOPNICD1/+ pituitaries. NICD1iresGFP positive cells do not express POMC in contrast with eYFP
positive cells in control embryos. (B) Immunofluorescence of 18.5dpc Nkx3.1Cre/+;Rosa26ReYFP and Nkx3.1Cre/+;Rosa26flSTOPNICD1/+. In control embryos,
IL melanotrophs express PAX7 and POMC while NICD1iresGFP positive cells in mutants are unable to upregulate POMC. Some show low levels of
PAX7 expression (arrowhead) suggesting commitment toward melanotroph fate. A few cells upregulate PAX7 and POMC in mutants, but are
NICD1iresGFP negative non-recombined cells (arrows). (C, D) Immunofluorescence of 18.5dpc Sox2CreERT2/+;Rosa26flSTOPNICD1/+pituitaries induced at
12.5dpc. NICD1iresGFP positive cells are now observed in IL. These express SOX2, but are POMC negative (high magnification inset). Similarly to what
is observed in Nkx3.1Cre/+;Rosa26flSTOPNICD1/+embryos, some NICD1iresGFP cells express PAX7 (D, arrowhead). (E) Immunofluorescence of 12.5dpc
Sox2CreERT2/+;Rosa26flSTOPNICD1/+ induced at 9.5dpc. Lower panel represents a magnification of the boxed area. NICD1iresGFP IL positive cells appear
clustered ventrally toward AL. E-cadherin staining is lost from the apical membranes of NICD;GFP positive cells. F-actin is stained using phalloidin. (F)
Immunofluorescence of 12.5dpc Sox2CreERT2/+;Rosa26flSTOPNICD1/+ induced at 9.5dpc. Lower panel represents a magnification of the boxed area.
Expression of ZO-1, along with that of E-cadherin is lost/altered from the apical membranes of the NICD;GFP positive cells that are closest to the cleft.
Therefore, both tight and adherent junctions appear abnormal in these cells, suggesting a loss of epithelial polarity. (G) Proportion of recombined cells
Figure 2 continued on next page
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induction of cell fate change within epithelial cells is known to result in cell extrusion (Bell and
Thompson, 2014; Bielmeier et al., 2016). We suggest that in IL, over-activation of NOTCH path-
way, resulting in blockade of cell commitment and therefore singling out mutant cells, induces an
apical extrusion of recombined cells toward AL. This phenomenon only happens in a narrow time
window because overactivation performed 72 hr later still leads to a blockade of cell fate acquisition,
but cell extrusion is no longer observed, or is significantly less efficient. Therefore, variations in tim-
ing and/or duration of NOTCH pathway activation result in strikingly different outcomes during IL
development, reflecting modulation of cell responses to NOTCH activation.
Expression of NICD in the POU1F1 lineage does not alter cell fate
acquisition, but post-natal function of somatotrophs is altered
We then decided to examine the effects of NOTCH overactivation in committed cells. POU1F1 is a
homeodomain transcription factor, exclusively expressed in the pituitary where it is required for the
post-natal expansion of somatotrophs, lactotrophs and thyrotrophs (Ward et al., 2006). It starts to
be expressed at 13.5dpc, marking cell commitment, and its expression is maintained in differenti-
ated somatotrophs, lactotrophs and thyrotrophs.
We thus generated Pou1f1-Cre;Rosa26flSTOPNICD1/+ and Pou1f1-Cre;Rosa26flSTOPNICD2/+ animals.
These are born and they display essentially normal growth curves, except for a transient delay
observed exclusively in males, which only reached significance in Pou1f1-Cre; Rosa26flSTOPNID2/+ ani-
mals (Figure 3A). We verified by RT-QPCR activation of NOTCH target genes and observed a
potent up-regulation of Hes5 in adult Pou1f1-Cre; Rosa26flSTOPNICD1and 2/+ pituitaries demonstrating
that the pathway is activated (Figure 3B).
Hormonal levels could be affected without altering animal weight therefore, we examined GH
pituitary contents by sandwich ELISA. We detected a significant decrease of pituitary GH in both
Pou1f1-Cre;Rosa26flSTOPNICD1/+ and Pou1f1-Cre;Rosa26flSTOPNICD2/+ 6 week-old pituitaries in males
and females (Figure 3C,D). This GH deficiency remains to a similar extent in 14-week-old Pou1f1-
Cre;Rosa26flSTOPNICD1/+ male mice, whilst becoming more severe in adult females. In contrast, there
was no reduction in pituitary GH in 14 week-old Pou1f1-Cre;Rosa26flSTOPNICD2/+ animals (Figure 3C).
We then examined the fate of recombined cells by immunofluorescence in 6 week-old animals,
given that GH deficiency is present in mutants. NICD1iresnucGFP-positive cells show expression of
differentiation markers such as GH, PRL and TSH suggesting that cell fate acquisition is not pre-
vented by NOTCH ectopic activation (Figure 3D).
These results are in sharp contrast with a previous study where a Pou1f1-NICD1 transgene was
shown to result in severe dwarfism and blockade of cell fate acquisition in the POU1F1 lineage
(Zhu et al., 2006). We thus decided to examine in more detail the effects of ectopic activation in the
embryo. When we compared NICD1iresnucGFP expression with that of eYFP in control embryos at
18.5dpc, we observed a similar pattern of recombination with recombined cells expressing POU1F1,
GH and TSH (Figure 4A, Figure 4—figure supplement 1). We did not examine lactotrophs as these
mostly emerge post-natally. We then examined NOTCH pathway activation by RT-qPCR at 18.5dpc
and observed a non-significant increase in Hes5 expression (Figure 4B), in contrast with the robust
up-regulation observed in adults (Figure 3B). Heyl and Hey1 expression levels are significantly up-
Figure 2 continued
located in the ventral half of IL in 12.5dpc Sox2CreERT2/+;Rosa26ReYFP and Sox2CreERT2/+;Rosa26flSTOPNICD1/+pituitaries induced at 9.5dpc. In control
Sox2CreERT2/+;Rosa26ReYFP pituitaries, eYFP positive cells are homogeneously distributed in IL (n = 5 embryos, 58 (±8.5 SD) cells were counted/embryo).
In contrast, 85% of NICD1iresGFP positive cells in mutant embryos are found in the ventral half of IL (n = 5 embryos, 29 (±23.6 SD) cells were counted/
embryo). Unpaired t test performed, p=0.0045 after angular transformation of percentages. An annotated picture illustrates how cells were counted in
dorsal and ventral IL. Scale bars represent 50 mm for A, C and D (upper panel), 20 mm for B and 10 mm for E (magnification) and F. IL is underlined.
DOI: https://doi.org/10.7554/eLife.33318.006
The following source data and figure supplement are available for figure 2:
Source data 1. Countings for graph G.
DOI: https://doi.org/10.7554/eLife.33318.008
Figure supplement 1. Contact between prospective IL and AL in control embryos.
DOI: https://doi.org/10.7554/eLife.33318.007
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Figure 3. Activation of NOTCH pathway in POU1F1 lineage alters somatotrophs post-natally. (A) Growth curves of Pou1f1-Cre; Rosa26flSTOPNICD1/+ and
Pou1f1-Cre; Rosa26flSTOPNICD2/+ animals. Male (M) and female (F) mutant (T) and wild-type (NT) littermates were monitored from weaning at 3 weeks of
age until 14 weeks of age. There is a transient significant weight reduction around puberty in Pou1f1-1Cre;R26flSTOPNICD2/+ animals. A similar tendency
is observed in Pou1f1-1Cre;R26flSTOPNICD1/+ animals but this does not reach significance. (n = 3 to 14 mice/sex and genotype, mixed-effects model of
Figure 3 continued on next page
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regulated but they are still well below activation levels observed post-natally for Hes5. In addition,
Pou1f1 expression levels are not affected in mutants.
In summary, ectopic expression of NICD in POU1F1-positive cells does not initially induce an effi-
cient activation of the NOTCH pathway. This suggests that in the embryo POU1F1-positive cells are
resistant to NOTCH activation. In consequence, cell fate acquisition is not affected and cells appar-
ently differentiate normally. In adult animals, however, the pathway ultimately becomes activated
and this correlates with an impairment of somatotroph function.
Loss of the NOTCH signalling mediator RBPj in the POU1F1 lineage
does not significantly affect endocrine function
We then investigated the consequences of inhibiting signalling transduced through all NOTCH
receptors, by conditional deletion of the NOTCH signalling mediator Rbpj. Pou1f1-Cre;Rbpjfl/fl mice
were born and they did not present any obvious phenotype. Growth curves did not reveal any signif-
icant weight differences from control littermates (Figure 5A). Furthermore, total pituitary GH con-
tents of male and female Pou1f1-Cre;Rbpjfl/fl mice at 6 and 14 weeks of age do not show any
significant changes (Figure 5B,C). Altogether these results suggest that physiologically, the classical
NOTCH signalling pathway does not play a significant role for somatotroph emergence and function
post-natally.
Activation of NOTCH pathway in the POMC lineage does not prevent
emergence of endocrine cells, but results in a progressive
downregulation of differentiation markers
Because POU1F1-positive cells appeared resistant to ectopic NOTCH activation, we wondered
whether this was true for other endocrine lineages. We therefore decided to investigate the effect of
NOTCH ectopic activation in the POMC lineage. It has previously been shown that ectopic activation
in this lineage using the same Rosa26flSTOPNICD1 allele results in loss of corticotrophs and melano-
trophs (Goldberg et al., 2011). Here, we used a different transgenic POMC-Cre exclusively active in
the pituitary, in essentially all melanotrophs, and half of corticotrophs (Langlais et al., 2013). We
have previously characterised this POMC-Cre and observed that the pattern of recombination
closely matches expression of the endogenous gene (Goldsmith et al., 2016).
Figure 3 continued
weight versus age was used, using genotype as fixed factors and subject (mice) as random factors, with analysis of variance (ANOVA) to test the overall
effect of genotype on growth, followed by Tukey post-hoc tests). (B) RT-qPCR analysis of NOTCH target genes in Pou1f1-1Cre;R26flSTOPNICD1 and 2/+
adult pituitaries. There is a significant increase in expression levels of three NOTCH targets, Hes1, Hes5 and Heyl in Pou1f1-1Cre;R26flSTOPNICD1/+
animals and Hes1, Hes5 and Hey1 in Pou1f1-1Cre;R26flSTOPNICD2/+ animals. This demonstrates that the pathway is overactivated (n = 3 to 6 pituitaries/
genotype in Pou1f1-Cre; Rosa26flSTOPNICD1/+ panel –NT- are Rosa26flSTOPNICD1/+ and –T- Pou1f1-Cre; Rosa26flSTOPNICD1/+ unpaired t test performed). (C)
Growth hormone (GH) pituitary contents were assayed by sandwich ELISA. GH contents of Pou1f1-1Cre;R26flSTOPNICD1/+ male (p=0.0003 at 6 weeks,
p=0.0032 at 14 weeks) and female (p=0.0048 at 6 weeks and p=0.0013 at 14 weeks) mice are significantly reduced at both 6 and 14 weeks of age
compared to wild-type littermates. In Pou1f1-1Cre;R26flSTOPNICD2/+there is only a transient deficit at 6week-old (p<0.0001 for males and p=0.0219 for
females). This shows that somatotrophs function is affected by NICD expression (n = 3 to 6 mice/sex and genotype, unpaired t test performed). (D)
Immunofluorescence of 6 week-old Pou1f1-1Cre;R26flSTOPNICD1/+pituitaries. NICD1iresGFP positive cells show expression of GH, PRL and TSH (with high
magnification inset), suggesting that somatotroph, lactotroph and thyrotroph cell fate acquisition has not been impaired by NOTCH activation. Scale
bar represent 50 mm.
DOI: https://doi.org/10.7554/eLife.33318.009
The following source data is available for figure 3:
Source data 1. Weights for Pou1f1Cre;R26 flSTOPNICD1/+ growth curves.
DOI: https://doi.org/10.7554/eLife.33318.010
Source data 2. Weights for Pou1f1Cre;R26 flSTOPNICD2/+ growth curves.
DOI: https://doi.org/10.7554/eLife.33318.011
Source data 3. GH contents for Pou1f1Cre;R26 flSTOPNICD1/+.
DOI: https://doi.org/10.7554/eLife.33318.012
Source data 4. GH contents for Pou1f1Cre;R26 flSTOPNICD2/+.
DOI: https://doi.org/10.7554/eLife.33318.013
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Figure 4. Expression of NICD1 in POU1F1 lineage does not alter cell fate acquisition in the developing pituitary and this correlates with inefficient
activation of NOTCH pathway. (A) Immunofluorescence of 18.5dpc Pou1f1-Cre;Rosa26ReYFP and Pou1f1-Cre;Rosa26flSTOPNICD1/+pituitaries. In both
control and mutant embryos, the pattern of recombination appears similar. EYFP, in controls, and NICD1iresGFP positive cells in mutants co-express
PIT1, GH or TSH, suggesting that cell fate acquisition is not altered. Scale bars represent 50 mm (upper panels, low magnification) and 10 mm (lower
Figure 4 continued on next page
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As previously described, we compared patterns of eYFP and NICDiresnucGFP expression in
respectively Pomc-Cre;Rosa26ReYFP/+ and Pomc-Cre;Rosa26flSTOPNICD1/+ at 18.5dpc (Figure 6A). Pat-
terns of recombination appear similar. Moreover, we observe in both genotypes co-localisation of
the fluorescent protein with POMC, both in AL corticotrophs and IL melanotrophs. Co-localisation
with PAX7 in IL demonstrates that melanotroph emergence occurs normally (Figure 6A).
In contrast with what was observed in Pou1f1-Cre;Rosa26flSTOPNICD1/+ embryos (Figure 4B), quan-
tification revealed a much more significant up-regulation of several NOTCH pathway target genes in
16.5 and 18.5dpc mutant pituitaries (Figure 6B), comparable with what we measured in Nkx3.1Cre/+;
Rosa26floxSTOPNICD1 and 2/+ embryos (Figure 1A). We examined Hes5 expression levels in more detail,
because it is the most robustly induced target, and observed a two-fold increase between 16.5dpc
and 18.5dpc (Figure 6C). This may reflect induction in melanotrophs, because these only start to
express POMC at 16.5dpc; however there may also be an increase in activation in corticotrophs. We
then examined expression levels of factors required for POMC lineage emergence and differentia-
tion (Figure 6D,E). Despite observing an apparent equivalent level of POMC staining by immunoflu-
orescence (Figure 6A), we detected a significant down-regulation of the gene expression at 18.5dpc
(Figure 6C). Expression of the transcription factor Tbx19, encoding a direct activator of Pomc
expression (Lamolet et al., 2001), and Ascl1, encoding for a basic helix loop helix (bHLH) transcrip-
tion factor expressed in the POMC lineage (Liu et al., 2001) were both significantly reduced. In con-
trast, expression of Neurod1, another bHLH factor transiently required for corticotroph
differentiation (Lamolet et al., 2004), was not affected. In melanotrophs, expression of Pax7 was
not significantly affected. In contrast, expression of the SC marker Sox9 was significantly upregu-
lated. Immunofluorescence for SOX9 at 18.5dpc shows a robust ectopic expression of the protein in
melanotrophs at 18.5dpc (Figure 6F). SOX2 is normally expressed in melanotrophs, but at lower lev-
els than in SC (Goldsmith et al., 2016). Immunofluorescence for SOX2 in Pomc-Cre;Rosa26flSTOP-
NICD1/+ melanotrophs suggested that levels were elevated and comparable to what we observe in
stem cells (Figure 6—figure supplement 1), but gene expression was not significantly altered in RT-
qPCR assays (data not shown). In AL, SOX2 and SOX9 are not up-regulated in NICD1iresGFP
corticotrophs.
Because POMC staining appeared normal (Figure 6A), while expression of the gene was signifi-
cantly downregulated at 18.5dpc (Figure 6D), this suggested that NOTCH activation was progres-
sively affecting the cells, and Pomc expression was gradually down-regulated. We therefore
examined expression of Pomc, Tbx19 and Neurod1 at 16.5dpc (Figure 6E). We observe a significant
down-regulation of Pomc and Tbx19 (respectively 50% and 65% decrease compared to Cre positive
samples), but this was not as dramatic as that observed at 18.5dpc (respectively 78% and 81%
decrease compared to Cre positive samples), strongly suggesting a progressive impairment of differ-
entiation as NOTCH activation becomes stronger (Figure 6D).
In summary, ectopic NOTCH activation does not appear to prevent emergence of corticotrophs
and melanotrophs, because POMC is clearly present in both cell types at 18.5dpc (Figure 6A). How-
ever, expression of both the hormone precursor, and its direct activator, Tbx19, are dramatically
downregulated during late gestation. We propose that sufficient levels of TBX19 during early devel-
opment, and normal levels of NEUROD1 may allow emergence of POMC positive cells (Figure 6D,
E). In parallel, we observe ectopic expression of SOX9 and slightly increased levels of SOX2, two
pituitary SC markers, in melanotrophs.
Figure 4 continued
panels, higher magnification). (B) RT-qPCR analysis of NOTCH target genes in Pou1f1-1Cre;R26flSTOPNICD1/+pituitaries at 18.5dpc. We only observe a
significant, but mild upregulation of Hey1 and Heyl in Pou1f1-1Cre;R26flSTOPNICD1/+pituitaries compared to both Pou1f1-1Cre and
R26flSTOPNICD1/+controls (n = 5 to 10 pituitaries/genotype, unpaired t test performed). Consequently, Pou1f1 expression levels are not affected in
mutants. This suggests that the pathway cannot be efficiently activated in the POU1F1 lineage.
DOI: https://doi.org/10.7554/eLife.33318.014
The following figure supplement is available for figure 4:
Figure supplement 1. Characterization of POU1F1-Cre by lineage tracing analysis at 18.5dpc.
DOI: https://doi.org/10.7554/eLife.33318.015
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Figure 5. Deletion of NOTCH pathway transcriptional mediator Rbpj in POU1F1 lineage has no effect on GH
levels. (A) Growth curves of Pou1f1-Cre;Rbpjfl/fl animals. Male (M) and female (F) mutant (T) and wild-type (NT)
littermates were monitored from weaning at 3 weeks of age until 14 weeks of age. There is no significant
difference between wild-type littermate and mutants (n = 3 to 9 mice/sex and genotype, mixed-effects model of
weight versus age was used, using genotype as fixed factors and subject (mice) as random factors, with analysis of
variance (ANOVA) to test the overall effect of genotype on growth, followed by Tukey post-hoc tests). (B, C) GH
Figure 5 continued on next page
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Activation of NOTCH pathway in the POMC lineage induces post-natal
regression of melanotrophs and corticotrophs to a progenitor-like state
Pomc-Cre;Rosa26flSTOPNICD1/+ animals are born and viable. In contrast with the POMC staining
observed at 18.5dpc in mutants (Figure 6A), but in agreement with a dramatic down-regulation of
the gene expression (Figure 6D), we observe early post-natally a spectacular reduction of POMC
staining in both IL and AL NICD1iresGFP-positive cells (Figure 7A). In 4 month-old animals
(Figure 7B–E), SOX9 is still ectopically and robustly expressed in the POMC negative, PAX7;SOX2
positive IL cells (Figure 7B,C). In contrast, in AL mutant corticotrophs, SOX2, but not SOX9, is ectop-
ically up-regulated (Figure 7D,E). We examined the expression of P57, a marker of post-mitotic
undifferentiated progenitors, and P27 whose expression replaces that of P57 in differentiated cells
(Bilodeau et al., 2009). While expression of P27 remains similar to controls in mutant IL, a few cells
re-activated expression of P57, in agreement with regression toward a progenitor state (Figure 7—
figure supplement 1).
Mutant ILs clearly appear thinner, however it is also noticeable that cell density is higher com-
pared to controls. To understand the origin of this difference, we initially examined cell apoptosis at
P2 but did not observe any TUNEL-positive staining in NICD1iresGFP-positive cells (Figure 7—fig-
ure supplement 2). We then examined cell proliferation at the same stage by quantifying EdU/PAX7
double positive cells and observed a significant increase in EdU incorporation in Pomc-Cre;Rosa26fl-
STOPNICD1/+ animals (Figure 7F). This is in agreement with induction of a progenitor-like fate, charac-
terised at these early post-natal stages by a much higher proliferative capacity compared to
differentiated cells (Gremeaux et al., 2012). We then quantified cell density in 5 month-old ILs and
observe a significant increase in mutants (Figure 7G), strongly suggesting that the reduction in IL
size is not due to reduced cell numbers, but to reduced cell volume, in agreement with a progeni-
tor-like identity of mutant cells.
Induction of Sox9 in response to NOTCH activation has previously been reported, and shown to
be of functional significance (Martini et al., 2013). We therefore investigated whether deletion of
Sox9 in Pomc-Cre;Rosa26flSTOPNICD1/+ could rescue the IL regression phenotype. We did not observe
an increase in POMC staining or IL thickness in 3 week-old Pomc-Cre;Rosa26flSTOPNICD1/+;Sox9fl/fl
samples (Figure 7H), demonstrating that SOX9 is not a mediator of NICD1 activation, at least for
these effects.
In summary, these data suggest that NOTCH activation results in a regression of POMC lineage
cells toward a stable progenitor-like state, but with different outcomes in IL (SOX2; SOX9 double
positive) and AL (SOX2 positive) cells.
Discussion
To better characterize the role of the NOTCH pathway during pituitary development, we have
manipulated its activity in a comparable manner in different cellular contexts. Our experiments
reveal an unexpected differential sensitivity to NICD expression between lineages and, in conse-
quence, provide a better understanding of the physiological role of the pathway during pituitary
development. Progenitors, normally exposed and responsive to NOTCH signalling, are sensitive to
Figure 5 continued
pituitary contents were assayed by sandwitch ELISA in 6 week-old (B, n = 3 to 6 pituitaries/sex and genotype) and
14 week-old (C, n = 3 to 7 pituitaries/sex and genotype) animals. There is no significant difference between wild-
type and mutant animals (unpaired t test performed).
DOI: https://doi.org/10.7554/eLife.33318.016
The following source data is available for figure 5:
Source data 1. Weights for Pou1f1Cre;RBPJfl/fl growth curves.
DOI: https://doi.org/10.7554/eLife.33318.017
Source data 2. GH contents for Pou1f1Cre;RBPJfl/fl 42 days-old.
DOI: https://doi.org/10.7554/eLife.33318.018
Source data 3. GH contents for Pou1f1Cre;RBPJfl/fl 100 days-old.
DOI: https://doi.org/10.7554/eLife.33318.019
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Figure 6. Activation of NOTCH pathway in the POMC lineage results in a gradual loss of differentiation markers in the embryo. (A)
Immunofluorescence of 18.5dpc Pomc-Cre;Rosa26ReYFP and Pomc-Cre;Rosa26flSTOPNICD1/+ pituitaries. In both control Pomc-Cre;Rosa26ReYFP and mutant
Pomc-Cre;Rosa26flSTOPNICD1/+ embryos, the pattern of recombination appears similar. EYFP, in controls, and NICD1iresGFP positive cells in mutants co-
express PAX7 and POMC (with high magnification inset), suggesting that cell fate acquisition is not altered. Fluorescence detection thresholds are
Figure 6 continued on next page
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its activation and this results in a blockade of cell fate acquisition. However, we show here that tim-
ing and/or duration of activation in progenitors differentially affects cell fate acquisition and mainte-
nance in the prospective IL. Strikingly, in differentiating endocrine cells, we then uncover that
NOTCH ectopic activation induces a blunted response in the POU1F1 lineage, while POMC-positive
cells remain sensitive to its effect. Consequently, cell fate acquisition and maintenance of differentia-
tion in POU1F1-positive cells is apparently not affected, suggesting that the NOTCH pathway does
not play a role for this process in this lineage. In agreement, deletion of the NOTCH effector RBPJ
has no apparent phenotypic consequence in this lineage. In contrast, in the POMC lineage, NOTCH
activation results in a gradual dedifferentiation of both corticotrophs and melanotrophs toward a
progenitor-like state. Taken together these results demonstrate first that the NOTCH pathway main-
tains progenitors in an undifferentiated state, however, response to activation is modulated in time
in dorsal progenitors. Second, sensitivity to NOTCH signalling in the developing pituitary varies in
the different endocrine lineages. We suggest that the maintenance of high responsiveness to
NOTCH activation in the POMC lineage, but not in the POU1F1 cells, points to a physiological
requirement for the NOTCH pathway to specifically prevent corticotroph and melanotroph cell
differentiation.
Role of NOTCH pathway in progenitors.
When NOTCH signalling is prevented in pituitary progenitors, either by deleting RBPJ (Zhu et al.,
2015; Zhu et al., 2006), the target genes Hes1 and Hes5 (Kita et al., 2007; Raetzman et al., 2007),
or the Notch2 receptor (Nantie et al., 2014), reduction of cell proliferation and precocious differen-
tiation are observed. Conversely, ectopic expression of Hes1 in both gonadotrophs and thyrotrophs
blocks their differentiation (Raetzman et al., 2007), and ectopic expression of Notch2 in the same
cells delays differentiation and maturation (Raetzman et al., 2006). This suggests that NOTCH sig-
nalling maintains progenitors in an undifferentiated state and that downregulation of its activity is
required for cells to differentiate, as observed in other tissues (for review see (Bray, 2016)). In agree-
ment with these studies (Kita et al., 2007; Raetzman et al., 2007; Zhu et al., 2015; Zhu et al.,
2006);(Nantie et al., 2014), we show here that maintained activation of the NOTCH pathway in pitu-
itary progenitors efficiently blocks cell fate acquisition. However, progression of progenitors, exem-
plified in the pituitary by the transition from an early SOX2-positive;SOX9-negative highly
proliferative cell to a SOX2;SOX9 double-positive more quiescent progenitor/SC at late gestation
(Rizzoti et al., 2016), does not appear to be prevented by NOTCH activity. This is because we still
observe up-regulation of SOX9 expression in Sox2CreERT2;Rosa26floxSTOP-NICD1 progenitors. There-
fore, NOTCH specifically affects cell fate acquisition, but apparently not other aspects of progenitor
identity and fate.
Blockade of cell fate acquisition appears more efficient in Sox2CreERT2;Rosa26floxSTOP-NICD1 pro-
genitors induced at 9.5dpc than in Nkx3.1Cre;Rosa26floxSTOP-NICD1 ones, because the proportion of
recombined cells that retain SOX2 expression is significantly higher in the former samples. In RP,
Figure 6 continued
identical between control and mutant. (B) RT-qPCR analysis of NOTCH pathway target genes in 18.5dpc pituitaries. There is a significant induction of
Hes5, Heyl, and Hey1 expression following NICD expression (n = 3 to 4 pituitaries/genotype unpaired t test performed). (C) RT-qPCR analysis of Hes5 in
16.5 and 18.5dpc Pomc-Cre;Rosa26flSTOPNICD1/+ pituitaries. Levels of Hes5 are doubling between 16.5 and 18.5dpc (n = 4 to 7 pituitaries/genotype,
unpaired t test performed). (D) RT-qPCR analysis of POMC lineage cell-type markers in 18.5dpc Pomc-Cre;Rosa26flSTOPNICD1/+ pituitaries. There is a
significant reduction of POMC, Tbx19 and Ascl1 expression while Sox9 is up-regulated. In contrast expression of Pax7 and Neurod1 is not significantly
affected (n = 4 to 6 pituitaries/genotype, unpaired t test performed). (E) RT-qPCR analysis of POMC lineage cell-type markers in 16.5dpc Pomc-Cre;
Rosa26flSTOPNICD1/+ pituitaries. The same tendency is observed, but downregulation is milder, suggesting that gene expression is further altered as
Hes5 induction becomes more robust (n = 5 to 7 pituitaries/genotype, unpaired t test performed). (F) Immunofluorescence of 18.5dpc
Rosa26flSTOPNICD1/+ and Pomc-Cre;Rosa26flSTOPNICD1/+ pituitaries. In the control Rosa26flSTOPNICD1/+ section, PAX7 is present in melanotrophs, while
SOX9 is restricted to stem cells lining the cleft in IL and AL, and glial cells in PL. PAX7 and SOX9 are hardly expressed by the same cells. In contrast, in
Pomc-Cre;Rosa26flSTOPNICD1/+ there is a clear co-localisation of SOX9 and PAX7 in IL. Scale bar represents 50 mm. IL is underlined.
DOI: https://doi.org/10.7554/eLife.33318.020
The following figure supplement is available for figure 6:
Figure supplement 1. In Pomc-Cre;Rosa26flSTOPNICD1/+ SOX2 expression levels appear similar in progenitors and melanotrophs.
DOI: https://doi.org/10.7554/eLife.33318.021
Cheung et al. eLife 2018;7:e33318. DOI: https://doi.org/10.7554/eLife.33318 16 of 25
Research article Developmental Biology and Stem Cells
Figure 7. Activation of NOTCH pathway in the POMC lineage results in regression of melanotrophs and corticotrophs toward a progenitor-like fate
post-natally. (A) Immunofluorescence of P7 wild-type and Pomc-Cre;Rosa26flSTOPNICD1/+ pituitaries. Expression of POMC is dramatically down-regulated
in IL and NICD1iresGFP positive corticotrophs in AL. SOX2 staining appears of similar intensity in both IL and SCs in mutants, while in control its
expression is clearly lower in IL melanotrophs compared to SCs. (B, C) Immunofluorescence of 4 month-old wild-type and Pomc-Cre;Rosa26flSTOPNICD1/+
IL. There is a clear co-localisation of PAX7 and SOX9 in mutant IL that is never observed in wild-type samples (B). POMC expression is almost absent in
the SOX2 positive IL cells in mutants (C). In addition, IL is thinner in mutants, while cell density appears increased. (D, E) Immunofluorescence of 4
month-old wild-type and Pomc-Cre;Rosa26flSTOPNICD1/+ AL. In contrast with what is observed in IL, SOX9 is not expressed in AL NICD1iresGFP positive
cells (D), but SOX2 is ectopically induced in the mutant cells (arrow, E). (F) Analysis of cell proliferation in PAX7 positive cells at P2. Pups were injected
with EdU and pituitaries harvested one hour later. There is a significant increase in cell proliferation in Pomc-Cre;Rosa26flSTOPNICD1/+ PAX7 positive cells
Figure 7 continued on next page
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Nkx3.1 is initially expressed at 10.5dpc, in a mosaic pattern, then up-regulated in the dorsal region
of RP at 12.5 until at least 14.5dpc (Treier et al., 2001). This domain encompasses that of SOX2
expression, and 70% of SOX2-positive cells are also EYFP-positive in 12.5dpc Nkx3.1Cre;Rosa26ReYFP
RPs (S. Goldsmith, PhD thesis). It is possible that some cells where Nkx3.1Cre is active are not pro-
genitors since we have not established co-localisation between NKX3.1 and SOX2 at all stages; this
would explain why fewer cells express SOX2 in Nkx3.1Cre;Rosa26floxSTOP-NICD1 compared to Sox2-
CreERT2;Rosa26floxSTOP-NICD1 pituitaries. However, it is likely that the earlier NOTCH activation is
induced, the more efficiently cell fate acquisition is prevented. This implies that, as progenitors prog-
ress toward commitment, some become less sensitive to its effects, perhaps those up-regulating
POU1F1 expression (see below), because we do observe some rare cells where SOX2 and POU1F1
co-localise (Fauquier et al., 2008).
The differential sensitivity of progenitors is also well illustrated by the contrasting effects of
NOTCH activation in IL progenitors. Indeed, in Sox2CreERT2;Rosa26floxSTOP-NICD1 embryos we observe
an exclusion of recombined cells from the future IL. This exclusion appears to be an active process
because recombined cells lose some epithelial characteristics and appear to integrate into the AL.
This process is reminiscent of a phenomenon recently described in Drosophila where juxtaposition,
within an epithelium, of cells with different fates results in extrusion of single cells (Bielmeier et al.,
2016). A similar mechanism could operate here, where recombined cells with higher levels of
NOTCH activity are singled-out because they are unable to commit to a dorsal/IL fate. Alternatively,
or in addition, NOTCH signalling activity is polarized in epithelial cells (Perez-Mockus and Schweis-
guth, 2017). It is therefore possible that our NICD expression approach directly affects epithelial
properties. Surprisingly, however, this effect is transient, because activation of the NOTCH pathway
72 hr later, using either Nkx3.1Cre or inducing Sox2CreERT2 at 12.5dpc, does not result in cell extru-
sion. Instead, as we observe in AL, cell fate acquisition is mostly prevented, with some rare cells
committing to a PAX7 positive melanotroph fate, but unable to progress to differentiation and to
up-regulate POMC expression. These data suggest that between 9.5 and 12.5 dpc a dorsal fate may
be imparted to cells in the prospective IL, and that this regionalisation information is sensitive to
NOTCH signalling.
NOTCH signalling in POU1F1 and POMC lineages.
The effects of NICD ectopic expression in the POU1F1 (Zhu et al., 2006) and POMC lineages
(Goldberg et al., 2011) have previously been reported. However, both the approaches used and
the outcomes are different from ours. Zhu et al engineered a POU1F1-NICD transgene and observe
a dramatic blockade of cell differentiation (Zhu et al., 2006), which is in sharp contrast with our
observations. This discrepancy may be explained by an earlier and maybe higher expression of the
POU1F1-NICD transgene compared to NICD in our Pou1f1-Cre;Rosa26flSTOPNICD1/+samples. If the
transgene was expressed in cells that are not yet committed, then blockade of cell differentiation
would be expected. Similarly, in the Pomc-Cre;Rosa26flSTOPNICD1/+ embryos described in Goldberg
et al, POMC expression is never detected, suggesting that corticotrophs and melanotrophs do not
Figure 7 continued
(n = 3 to 4 pups/genotype, unpaired t test performed, p=0.0013 is calculated after angular transformation of percentages). (G) Analysis of cell density in
5 month-old IL (n = 3 to 4 pituitaries/genotype, unpaired t test performed, p=0.0011). (H) Immunofluorescence for SOX9 and POMC in 3 week-old
pituitaries. Despite loss of ectopic SOX9 expression in Pomc-Cre;Rosa26flSTOPNICD1/+;Sox9 fl/fl POMC expression is still down-regulated in the
hypoplastic IL. Scale bar represent 50 mm in A, H and in B for C-E. IL is underlined.
DOI: https://doi.org/10.7554/eLife.33318.022
The following source data and figure supplements are available for figure 7:
Source data 1. Countings for graph F.
DOI: https://doi.org/10.7554/eLife.33318.025
Source data 2. Countings for graph G.
DOI: https://doi.org/10.7554/eLife.33318.026
Figure supplement 1. P57 is up-regulated in some cells in Pomc-Cre;Rosa26flSTOPNICD1/+ IL.
DOI: https://doi.org/10.7554/eLife.33318.023
Figure supplement 2. Reduction of intermediate lobe size in Pomc-Cre;Rosa26flSTOPNICD1/+ pituitaries is not due to cell apoptosis.
DOI: https://doi.org/10.7554/eLife.33318.024
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emerge, again in contrast with our results. This discrepancy could be explained by an earlier expres-
sion of the Pomc-cre transgene (Balthasar et al., 2004) used in Goldberg et al, which is different
from the one used here (Langlais et al., 2013). We have previously characterised this Cre transgene
(Langlais et al., 2013) in the embryonic pituitary, and showed that it matches endogenous POMC
expression (Goldsmith et al., 2016).
Consistently, our results show that neither ectopic expression of NICD, nor deletion of RBPJ in
the POU1F1 lineage affect cell fate acquisition. In agreement with an apparent absence of a pheno-
typic effect, we show that ectopic expression of NICD hardly affects expression of NOTCH target
genes in the embryonic pituitary, demonstrating that the cells are relatively insensitive to its effect.
This lack of responsiveness may be explained by sequestration of NOTCH responsive enhancers by
other factors, as observed in different contexts (for review see (Bray, 2016)). Therefore, the classical
NOTCH pathway is unlikely to be directly involved for POU1F1 lineage commitment and differentia-
tion. However, there is a significant activation of the pathway by NICD post-natally and a reduction
in GH production and secretion, therefore, the NOTCH pathway activation compromises some
aspects of somatotroph function.
In contrast, in the POMC lineage, responsiveness to NICD expression is comparable to what is
observed in progenitors. Following activation, expression of Tbx19 (Lamolet et al., 2001), the key
determinant of melanotroph and corticotroph identity, is gradually downregulated in the embryo.
However, expression of Neurod1 (Lamolet et al., 2004), transiently required for early corticotroph
differentiation, is not significantly affected. Both TBX19 and NEUROD1 can activate the expression
of POMC (Lamolet et al., 2001) (Poulin et al., 1997). We therefore propose that unaffected levels
of NEUROD1 and sufficient levels of TBX19 in early stages of terminal differentiation allow up-regu-
lation of POMC expression in Pomc-Cre;Rosa26flSTOPNICD1/+ corticotrophs. Corticotrophs are the first
pituitary endocrine cells to up-regulate expression of the hormone they secrete. Our results point to
a direct and specific effect of NOTCH signalling in preventing their differentiation, presumably
through down-regulation of Tbx19. This is in agreement with results obtained in pituitary organoids
(Suga et al., 2011) where efficient and specific generation of corticotrophs is observed after inhibi-
tion of NOTCH pathway. In IL, expression of the melanotroph pioneer factor Pax7 is not affected,
therefore cell fate acquisition is not impaired by NOTCH activation. However, as observed in cortico-
trophs, gradual downregulation of Tbx19 results in loss of POMC expression post-natally.
Regression of both IL and AL in cells with Pomc-Cre;Rosa26flSTOPNICD1/+ is associated with up-reg-
ulation of the pituitary SC markers SOX2 and SOX9 (Rizzoti et al., 2013). This suggests that the cells
partially dedifferentiate. In agreement with this hypothesis, IL mutant cells proliferate more, at least
early post-natally. We observe a differential expression of the two SOX transcription factors post-
natally: SOX9 is strongly up-regulated and maintained in Pomc-Cre;Rosa26flSTOPNICD1/+ IL but not in
AL. In contrast SOX2, normally present in melanotrophs (Goldsmith et al., 2016), is up-regulated in
Pomc-Cre;Rosa26flSTOPNICD1/+ corticotrophs. Both factors belong to different SOX families therefore,
they do not perform redundant functions. In addition, in different cellular contexts, expression of
SOX2 (Pan et al., 2013) or SOX9 (Martini et al., 2013) is induced in response to NOTCH activation,
and this is required for NOTCH-dependant progenitor maintenance. The significance of this differen-
tial expression is unclear. However we show here that deletion of Sox9 in Pomc-Cre;Rosa26flSTOP-
NICD1/+ pituitaries does not prevent IL regression, suggesting that SOX9 does not play a significant
role in the phenotype. Further analysis is necessary to better characterise the role of these factors
following NOTCH activation in the POMC lineage.
In conclusion, the regression of both melanotrophs and corticotrophs observed in response to
NICD expression shows that the NOTCH pathway most likely has a direct role in preventing POMC
lineage differentiation. In addition, the lasting sensitivity of this lineage to NOTCH activation and its
dedifferentiating effect may be of relevance in pathological situations, such as tumorigenesis. This
also raises the possibility that this lineage may be more easily reprogrammed, potentially to promote
regeneration. It is tempting to speculate that this specificity reflects the absolute requirement for a
functioning hypothalamo-pituitary-adrenal axis for survival. Further characterization of NICD action
in this lineage is now essential.
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Materials and methods
Key resources table
Reagent type
(species)
or resource Designation Source or reference Identifiers Additional information
strain, strain
background
(mus musculus)
Nkx3.1Cre Lin, Y., Liu, G., Zhang, Y., Hu, Y.P., Yu, K.,
Lin, C., McKeehan, K., Xuan, J.W.,
Ornitz, D.M., Shen, M.M., et al. (2007).
Fibroblast growth factor receptor 2
tyrosine kinase is required for prostatic
morphogenesis and the acquisition of strict
androgen dependency for adult tissue
homeostasis. Development 134, 723–734.
Nkx3-1tm3(cre)Mms
strain, strain
background
(mus musculus)
Sox2CreERT2 Arnold, K., Sarkar, A., Yram, M.A., Polo, J.M.,
Bronson, R., Sengupta, S., Seandel, M.,
Geijsen, N., and Hochedlinger, K. (2011).
Sox2(+) adult stem and progenitor cells are
important for tissue regeneration and
survival of mice. Cell Stem Cell 9, 317–329.
Sox2tm1(cre/ERT2)Hoch
strain, strain
background
(mus musculus)
Pou1f1-Cre this paper (nogene)Tg(pou1f1-cre)1Rsd
strain, strain
background
(mus musculus)
Rbpjfl Han, H., Tanigaki, K., Yamamoto, N., Kuroda, K.,
Yoshimoto, M., Nakahata, T., Ikuta, K., and
Honjo, T. (2002). Inducible gene knockout
of transcription factor recombination
signal binding protein-J reveals its essential
role in T versus B lineage decision.
Int Immunol 14, 637–645.
RBPJtm1Hon
strain, strain
background
(mus musculus)
Rosa26ReYFP Srinivas, S., Watanabe, T., Lin, C.S.,
William, C.M., Tanabe, Y., Jessell, T.M.,
and Costantini, F. (2001).
Cre reporter strains produced by
targeted insertion of EYFP and ECFP into
the ROSA26 locus. BMC Dev Biol 1, 4.
Gt(Rosa26)Sortm1(EYFP)Cos
strain, strain
background
(mus musculus)
Rosa26floxSTOP-Nicd1 Murtaugh, L.C., Stanger, B.Z., Kwan, K.M., and
Melton, D.A. (2003). Notch signaling controls
multiple steps of pancreatic differentiation. Proc
Natl Acad Sci U S A 100, 14920–14925.
Gt(Rosa26)Sortm1(Notch1)Dam
strain, strain
background
(mus musculus)
Rosa26floxSTOP-Nicd2 Fujimura, S., Jiang, Q., Kobayashi, C., and
Nishinakamura, R. (2010). Notch2 activation in
the embryonic kidney depletes nephron
progenitors. J Am Soc Nephrol 21, 803–810.
Gt(Rosa)26Sortm1(Notch2)Nis
strain, strain
background
(mus musculus)
Pomc-Cre Langlais, D., Couture, C., Kmita, M., and
Drouin, J. (2013). Adult pituitary cell
maintenance: lineage-specific contribution
of self-duplication. Mol
Endocrinol 27, 1103–1112.
Antibody goat anti-Sox2 ISS GT15098 1/300
Antibody rat anti-GFP Fine Chemical products 04404–84 1/1000
Antibodies anti pituitary
hormones
NHPP
Antibody mouse anti-Pax7 DSHB P3U1 1/100
Mice
Nkx3.1Cre (Nkx3-1tm3(cre)Mms (Lin et al., 2007), Sox2CreERT2 (Sox2tm1(cre/ERT2)Hoch (Arnold et al.,
2011), Pou1f1-Cre ((nogene)Tg(pou1f1-cre)1Rsd), Rbpjfl (RBPJtm1Hon (Han et al., 2002), Rosa26ReYFP(Gt
(Rosa26)Sortm1(EYFP)Cos (Srinivas et al., 2001), Rosa26floxSTOP-Nicd1 (Gt(Rosa26)Sortm1(Notch1)Dam
(Murtaugh et al., 2003), Rosa26floxSTOP-Nicd2(Gt(Rosa)26Sortm1(Notch2)Nis (Fujimura et al., 2010) and
Pomc-Cre ((nogene)Tg(PomC-Cre)Dro (Langlais et al., 2013) were maintained on mixed background.
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Pou1f1-Cre mice were generated by first inserting the cDNA coding for NLS-CRE between rabbit
beta-globin intron and beta globin polyA sequences. Tissue specific expression of CRE to the pitui-
tary gland was obtained by inserting a 15 kb upstream promoter sequence of the Pou1f1 gene.
Finally, the transgene was cloned between insulator sequences of the beta globin gene to prevent
silencing of transgene expression in vivo. Pou1f1-Cre transgenic animals were obtained by standard
pronuclear injection. Tissue-specific expression of CRE to the Pou1f1 lineage was confirmed by
crossing the obtained Pou1f1-Cre mouse line with Rosa26ReYFP mice. Cre activity in Sox2CreERT2/+;
Rosa26floxSTOP-NICD1 embryos was induced by a single tamoxifen treatment (0.2 mg/g/day) in preg-
nant females. Weights of mice were recorded weekly between age-matched littermates after wean-
ing at 3 weeks of age.
Immunofluorescence, EdU staining, microscopy and imaging
Immunofluorescence was performed following a previously described protocol (Cheung, 2013
#1301). Mice were perfused with 4% w/v paraformaldehyde in phosphate-buffered saline (PBS),
pituitaries harvested and cryosectioned at 12 mm. Sections were blocked with blocking solution (10%
v/v donkey serum in PBS/0.1% v/v Triton X-100; PBST) for 1 hr, then incubated with primary antibod-
ies in 10% blocking solution overnight at 4˚C. Primary antibodies were used at the following dilu-
tions: rat anti-GFP (Nacalai Tesque) at 1:1000; monkey anti-rat GH (NHPP) at 1:5000; rabbit anti-
POMC, GH, TSH and PRL (NHPP) at 1:500; mouse anti-POMC (Sigma) 1:1000, goat anti-POU1F1
(Santa Cruz) at 1:100, Rb anti-POU1F1 (gift from S.Rhodes, Indiana University School of Medicine) at
1: 500, Mouse anti-PAX7 (DSHB) 1:100, goat anti-SOX2 (Immune System) at 1:300, rabbit anti-SOX9
(gift from F.Poulat, Institut de Ge´ne´tique Humaine, Montpellier) at 1:300. Sections were washed in
PBST then incubated for 1 hr at room temperature with the corresponding anti-rat, anti-goat, anti-
rabbit, or anti-human secondary antibody conjugated to Alexa-Fluor 488,–555,  594, or  647 in
10% blocking solution with 1 mM 4’,6-diamino-2-phenylindole (DAPI). Cell proliferation was analysed
following a one hour EdU pulse (30 mg/g body weight). Incorporation was detected using a Click-iT
EdU imaging kit following the manufacturer instructions (Thermo Fisher Scientific). Sections were
washed with PBST and mounted using Aqua-Poly/Mount (Polysciences, Inc., Warrington, PA, USA).
Fluorescent signal was captured using a Leica SPE confocal microscope.
3D reconstruction images were generated using serial haematoxylin and eosin-stained sections
from Nkx3.1Cre; Rosa26floxSTOP-NICD/+1 and Nkx3.1Cre; Rosa26floxSTOP-NICD2/+ embryos and controls.
Sections were first imaged using an Olympus VS120 slide scanner. Images were then aligned with
FIJI, and false-coloured using the ilastik 0.5 software (Sommer et al., 2011). Volocity software (Per-
kin Elmer) was used to create 3D reconstructions of these images.
Cell countings
For EdU quantification, PAX7 positive cells and EdU positive cells were counted in three sections/
embryos in three embryos/genotype. For cell density quantification, on 3 DAPI stained sections/sam-
ple (minimum three samples/genotype), nuclei were counted in a representative fixed surface area.
mRNA extraction and reverse transcriptase-PCR (rt-qPCR)
Total mRNA was extracted from dissected embryonic and postnatal pituitary glands using the
RNeasy Mini and Micro kits (Qiagen) according to the manufacturer’s protocol. The extracted mRNA
was transcribed into cDNA using the Quantitech Reverse Transcription kit (Qiagen, for Figures 1
and 3) or the Superscript VILO cDNA synthesis kit (Thermo Fisher Scientific, for Figures 4 and
6) according to the manufacturer’s protocol.
Quantitative real-time PCR (RT-qPCR)
Each sample was assayed in technical duplicate with each tube containing diluted template cDNA,
250 nM primers and 1xSensiMixSybr (QuantACE, Figures 1 and 3) or 1xAbsoluteSybrGreen ROX
mix (Thermo Fisher Scientific, for Figures 4 and 6). Each sample was assayed for the genes of inter-
est together with three reference housekeeping genes: Atp5b, Sdha, and Eif1a2 (Figures 1 and
3) or using one reference housekeeping gene, Gapdh (Figures 4 and 6). Relative expression of the
genes of interest were calculated by normalisation of the detected expression value to the geomet-
ric mean of the reference genes using the DDCt method (Bustin et al., 2009; Livak and Schmittgen,
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2001). The primers used for RT-qPCR are listed in Supplementary file 1. Data is shown as ±mean
SEM for a minimum of 3 samples/data point.
Sandwich enzyme-linked immunosorbent assay (ELISA)
Experimental data were collected from virgin male and female mice, unless otherwise stated. Total
pituitary GH contents were assayed using a previously described method (Steyn et al., 2011) using
mouse-specific reagents kindly provided by A.F. Parlow (National Hormone and Pituitary Program
(NHPP), Torrance, CA, USA).
Statistical analyses
Quantitative PCR, growth curves and GH assays results are presented as means ± standard error of
the mean (SEM). Other quantifications are presented as means ± standard deviation (SD). When
comparing two groups of values, the unpaired Student’s t-test was used to produce a p-value. When
repeated measurements from the same samples were taken (i.e. growth curves), a mixed-effects
model of weight versus age was used, using genotype as fixed factors and subject (mice) as random
factors, with analysis of variance (ANOVA) to test the overall effect of genotype on growth, followed
by Tukey post-hoc tests. Standard significance levels were used: *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001.
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